During the past decade, Vasculair Onderzoek Centrum Hoorn conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vasculair Onderzoek Centrum Hoorn" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Cytel Inc." with 1 trials as a collaborator and "Worldwide Clinical Trials" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Vasculair Onderzoek Centrum Hoorn" are "Dyslipidemia" (2 trials), "Heart Failure" (2 trials), "Hypercholesterolemia" (2 trials), "Acute Myocardial Infarction" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Vasculair Onderzoek Centrum Hoorn" in a lesser frequency.

Most popular intervention types in "Vasculair Onderzoek Centrum Hoorn" are "Drug" (8 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Pitavastatin" (4 trials), "Placebo" (3 trials), "Empagliflozin" (2 trials), "Atorvastatin" (1 trials) and "Normal saline 0.9%" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vasculair Onderzoek Centrum Hoorn" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Vasculair Onderzoek Centrum Hoorn". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 7 completed trials in Vasculair Onderzoek Centrum Hoorn, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Vasculair Onderzoek Centrum Hoorn, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".